Martin J Driscoll
CIK 1339402 · President and CEO · last filed 2020-11-23
Martin J Driscoll is a President and CEO who has filed 47 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for SBPH, was dated Nov 23, 2020. Across all open-market trades the lifetime net is +$782.2K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
47
$782.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| F-star Therapeutics, Inc. (SBPH) Delisted | President and CEO | 32,600 | — | — | $611.7K | 26 | 2020-11-23 |
| JAVELIN PHARMACEUTICALS, INC (JAV) Delisted | Chief Executive Officer | 0 | — | — | $170.6K | 13 | 2010-07-02 |
| GNTA | Director | — | $1.87 | — | $0 | 1 | 2007-07-12 |
Recent Filings
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-11-23 | F-star Therapeutics, Inc. (SBPH) Delisted | Mixed | +24,825 | -$833 | EDGAR |
| 2020-03-09 | F-star Therapeutics, Inc. (SBPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-11-14 | F-star Therapeutics, Inc. (SBPH) Delisted | Buy (P) | +5,000 | $14.2K | EDGAR |
| 2019-05-29 | F-star Therapeutics, Inc. (SBPH) Delisted | Buy (P) | +10,000 | $60.3K | EDGAR |
| 2019-05-22 | F-star Therapeutics, Inc. (SBPH) Delisted | Buy (P) | +5,000 | $33.1K | EDGAR |
| 2019-04-30 | F-star Therapeutics, Inc. (SBPH) Delisted | Buy (P) | +10,000 | $73.3K | EDGAR |
| 2019-01-25 | F-star Therapeutics, Inc. (SBPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-08-13 | F-star Therapeutics, Inc. (SBPH) Delisted | Buy (P) | +4,000 | $48.1K | EDGAR |
| 2018-03-01 | F-star Therapeutics, Inc. (SBPH) Delisted | Buy (P) | +1,000 | $12.8K | EDGAR |
| 2018-01-17 | F-star Therapeutics, Inc. (SBPH) Delisted | Grant (A) | — | $0 | EDGAR |